SCHEMBL4283479

SCHEMBL4283479

NC(=O)CC[C@@H](N)CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.54
BLM P54132 1/20 0.54
PMP22 Q01453 1/20 0.54
KMT2A Q03164 1/20 0.54
ENPEP Q07075 6/20 0.46
ANPEP P15144 3/20 0.46
LTA4H P09960 1/20 0.41
BMP1 P13497 1/20 0.41
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27999571 1.00 ALOX15 (0.54) ALOX15BLMPMP22KMT2AENPEP
SCHEMBL288131 1.00 ALOX15 (0.54) ALOX15BLMPMP22KMT2AENPEP
SCHEMBL284914 0.88 ENPEP (0.52) ALOX15BLMPMP22KMT2AENPEP
SCHEMBL289006 0.88 ENPEP (0.52) ALOX15BLMPMP22KMT2AENPEP
SCHEMBL289102 0.85 ENPEP (0.62) BLMKMT2AENPEPANPEPLTA4H
SCHEMBL288129 0.85 ENPEP (0.62) BLMKMT2AENPEPANPEPLTA4H
SCHEMBL42056 0.85 ENPEP (0.62) BLMKMT2AENPEPANPEPLTA4H
SCHEMBL3690946 0.83 ENPEP (0.60) BLMKMT2AENPEPANPEPLTA4H
Hydrochloric Acid SCHEMBL7366627 0.83 ENPEP (0.60) BLMKMT2AENPEPANPEPLTA4H
SCHEMBL16860717 0.83 ENPEP (0.64) ALOX15BLMPMP22KMT2AENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670151-A Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens 犹他大学研究基金会 2023-08-29 CN claimed
EP-4651906-A1 ANTI-CD70 ANTIBODY-DRUG CONJUGATES Ambrx, Inc. (US) 2025-11-26 EP disclosed
EP-4598586-A1 DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF Ambrx, Inc. (US) 2025-08-13 EP disclosed
CN-104984319-B TFPI inhibitors and methods of use 武田药品工业株式会社 2025-05-09 CN disclosed
WO-2025041055-A1 ANTI-PSMA ADC CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF AMBRX, INC. (US) 2025-02-27 WO disclosed
WO-2024215515-A1 DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF AMBRX, INC. (US) 2024-10-17 WO disclosed
CN-118613492-A TFPI binding polypeptides and uses thereof 西湖大学 2024-09-06 CN disclosed
WO-2024155627-A1 ANTI-CD70 ANTIBODY-DRUG CONJUGATES AMBRX, INC. (US) 2024-07-25 WO disclosed
WO-2024077277-A1 DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF AMBRX, INC. (US) 2024-04-11 WO disclosed
CN-116419919-A Subcutaneous and intramuscular administration of pyrazine compounds 麦迪贝肯有限公司 2023-07-11 CN disclosed
CN-110545854-A method for renal function determination MEDIBEACON INC 2019-12-06 CN disclosed
WO-2009141384-A2 PROCESS FOR THE PURIFICATION OF FACTOR VII POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS NOVO NORDISK A/S (DK) 2009-11-26 WO disclosed